COVID Vaccine Preprint Study Prompts Twitter Outrage

Translate to Spanish or other 102 languages!

Image for illustration for Illustration purposes.

Medscape

- Advertisement -

A preprint study finding that the Pfizer-BioNTech mRNA COVID vaccine is associated with an increased risk for cardiac adverse events in teenage boys has elicited a firestorm on Twitter. 

Although some people issued thoughtful critiques, others lobbed insults against the authors, and still others accused them of either being anti-vaccine or stoking the fires of the vaccine skeptic movement.

For the complete story, click on the following link: https://www.medscape.com/viewarticle/958778?uac=209076CT&faf=1&sso=true&impID=3641968&src=mkm_covid_update_210915_MSCPEDIT

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS Children’s & Spirit Halloween Bring Spooktacular Fun to Young Patients

Mega Doctor News EDINBURG, Texas - Halloween came a little early for young...

STC Offers EKG Technician Training to Prepare Students for Careers in Healthcare

South Texas College (STC) is offering an electrocardiography (EKG) technician course through its Continuing Education and Workforce Development division, providing students with hands-on training and an opportunity to take the first step toward a career in healthcare. 

FDA Approves First Treatment for Certain People With BCG-Unresponsive Bladder Cancer  

The U.S. Food and Drug Administration expanded the approved use of Anktiva (nogapendekin alfa inbakicept-pmln), given with Bacillus Calmette-Guérin (BCG), to include adults with high-grade papillary-only bladder cancer that has not spread into the bladder muscle and has not responded to BCG treatment.

Do You Want to Be an Angel? This Is Your Opportunity

Becoming an angel for someone facing cancer may be as simple as donating $3 or $5. Through DHR Health’s annual Bras for a Cause fundraiser, community members can help patients experiencing financial difficulties while supporting breast cancer awareness and early detection.
- Advertisement -